Back to top

Promising Clinical Trials and Strategic Financial Management Affirm Buy Rating for Affimed

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Affimed (AFMD – Research Report), with a price t...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Affimed N.V. (AFMD)